Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What CAGR And Valuation Are Anticipated For The Geographic Atrophy Market?

In recent times, the market size for geographic atrophy has seen rapid expansion. The growth is expected to surge from $1.86 billion in 2024 to $2.11 billion in 2025, with a compound annual growth rate (CAGR) of 13.7%. Factors contributing to the growth during this period include an expanding elderly population, increased demand for effective treatments, growing incidences of geographic atrophy, enhanced health awareness, and a rise in retinal disease occurrences.

Expectations point towards a swift expansion in the geographic atrophy market size in the upcoming years. With a compound annual growth rate (CAGR) of 13.2%, the market is predicted to escalate to $3.47 billion by 2029. The projected expansion during this forecast period is due to an intensified focus on research and development, a rise in R&D funding, an upsurge in smartphone usage, amplified spending on healthcare, and augmented investments in clinical trials. In the same forecast period, significant trends likely to impact the market include progress in gene therapy techniques, advancements in healthcare tech, the creation of innovative technologies, the adoption of telemedicine, and the development of novel, effective medications.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21984&type=smp

What Are The Primary Factors Supporting The Geographic Atrophy Market Expansion?

The spike in incidences of age-related macular degeneration (AMD) is anticipated to stimulate the expansion of the geographic atrophy market in the future. AMD is an eye disorder that chiefly affects the elderly, damaging the central part of the retina and impairing the ability to see fine details. The rising aging population mostly contributes to the prevalence of AMD, due to an increased lifespan and the natural deterioration of eyes as a result of aging, which heightens susceptibility to the disease over time. Treatments for geographic atrophy aid AMD patients by minimizing the progression of retinal damage and safeguarding the remaining vision. For example, a report released by Medical News Today, a digital media company based in the US, predicted in January 2024 that global incidences of AMD will escalate from 196 million to 288 million by 2040. Thus, the growing prevalence of age-related macular degeneration is propelling the expansion of the geographic atrophy market.

Which Segments Define The Structure Of The Geographic Atrophy Market?

The geographic atrophymarket covered in this report is segmented –

1) By Drug Type: Anti-Vascular Endothelial Growth Factor (VEGF) Therapy; Complement Inhibitors; Neuroprotective Agents; Other Drugs

2) By Diagnosis: Fundus Autofluorescence (FAF); Optical Coherence Tomography Angiography (OCT-A); Multifocal Electroretinography (mfERG)

3) By Route Of Administration: Intravitreal; Oral; Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels

Subsegments:

1) By Anti-Vascular Endothelial Growth Factor (VEGF) Therapy: Ranibizumab; Aflibercept; Bevacizumab

2) By Complement Inhibitors: Pegcetacoplan; Lfg316

3) By Neuroprotective Agents: Latanoprost; Brimonidine

4) By Other Drugs: Steroids; Retinoids; Combination Therapy

Which Long-Term Trends Will Play A Crucial Role In The Geographic Atrophy Market?

In the geographic atrophy market, companies are advancing complement inhibitor therapies to develop cutting-edge treatments. These therapies reduce overactive immune responses linked to disease progression, protecting healthy cells and slowing degeneration. For example, in February 2025, Astellas Pharma Inc., a Japan-based company, announced FDA approval for IZERVAY (avacincaptad pegol intravitreal solution) to treat geographic atrophy secondary to age-related macular degeneration (AMD). The approval allows unlimited dosing duration, offering greater treatment flexibility for patients and providers.

Who Are The Primary Market Leaders In The Geographic Atrophy Market?

Major companies operating in the geographic atrophy market are Regeneron Pharmaceuticals Inc., Boehringer Ingelheim, Astellas Pharma Inc., Biogen Inc., Ocugen Inc., Kodiak Sciences Inc., Apellis Pharmaceuticals Inc., NGM Biopharmaceuticals Inc., Voyager Therapeutics, Kriya Therapeutics, Stealth BioTherapeutics, Kiora Pharmaceuticals, Iveric Bio, Alkeus Pharmaceuticals, Nanoscope Therapeutics, Graybug Vision, SparingVision, 4D Molecular Therapeutics, Clearside Biomedical, Gensight Biologics

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/geographic-atrophy-global-market-report

What Regional Factors Are Accelerating Growth In The Geographic Atrophy Market?

North America was the largest region in the geographic atrophy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the geographic atrophy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21984&type=smp

Browse Through More Reports Similar to the Global Geographic Atrophy Market 2025, By The Business Research Company

Dry Eye Medication Market 2025

https://www.thebusinessresearchcompany.com/report/dry-eye-medication-market

Dry Eye Medication Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dry-eye-medication-global-market-report

Eyewear Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/eyewear-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model